Nymox Pharmaceutical Quote - NYMX

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

0.20

Bid

0.2003

Ask

0.2169

Volume

0.00 Day's Range 0.00

0.00 52 Week Range 0.00

Market Cap

18.708M

Previous Close

0.20

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

Shares Outstanding

93,540,000

Dividend Yield

PE Ratio

-2.12

Earnings Per Share (EPS)

-0.09

Revenue

Net Profit

-8.84M

Nymox Pharmaceutical Corp is a biopharmaceutical company focused on developing its drug candidate, NX-1207, for the treatment of BPH and the treatment of low-grade localized prostate cancer. Nymox Pharmaceutical Corp is a biopharmaceutical company focused on developing its drug candidate, NX-1207, for the treatment of BPH and the treatment of low-grade localized prostate cancer.

Sector

Chemicals & Chem Preps, Nec

Industry

Chemicals & Chem Preps, Nec

Website

www.nymox.com

Headquarters

Nassau, Bhs

Founded

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

NYMX - Frequently Asked Questions (FAQ)

What is the current Nymox Pharmaceutical share price?

The current share price of Nymox Pharmaceutical is US$ 0.20

How many Nymox Pharmaceutical shares are in issue?

Nymox Pharmaceutical has 93,540,000 shares in issue

What is the market cap of Nymox Pharmaceutical?

The market capitalisation of Nymox Pharmaceutical is USD 18.71M

What is the 1 year trading range for Nymox Pharmaceutical share price?

Nymox Pharmaceutical has traded in the range of US$ 0.00 to US$ 0.00 during the past year

What is the PE ratio of Nymox Pharmaceutical?

The price to earnings ratio of Nymox Pharmaceutical is -2.12

What is the reporting currency for Nymox Pharmaceutical?

Nymox Pharmaceutical reports financial results in USD

What is the latest annual profit for Nymox Pharmaceutical?

The latest annual profit of Nymox Pharmaceutical is USD -8.84M

What is the registered address of Nymox Pharmaceutical?

The registered address for Nymox Pharmaceutical is BAY & DEVEAUX STS., 2ND FLOOR, NASSAU, H4M 2V2

What is the Nymox Pharmaceutical website address?

The website address for Nymox Pharmaceutical is www.nymox.com

Which industry sector does Nymox Pharmaceutical operate in?

Nymox Pharmaceutical operates in the CHEMICALS & CHEM PREPS, NEC sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
XOSXos Inc	US$ 5.7798 (84.66%)	29.01M
SHOTWSafety Shot Inc	US$ 0.37 (73.55%)	10.27k
WOKWORK Medical Technology Group Ltd	US$ 4.2271 (69.76%)	69.06M
MNDRMobile health Network Solutions	US$ 0.5056 (53.54%)	61.91M
LUNGPulmonx Corporation	US$ 8.93 (34.49%)	815.08k
MTLSMaterialise NV	US$ 6.43 (-30.26%)	401.13k
PLTUDirexion DAily PLTR Bull 2X Shares	US$ 42.23 (-22.92%)	2.18M
PTIRGraniteShares 2X Long PLTR Daily ETF	US$ 199.6141 (-22.84%)	858.94k
COEPCoeptis Therapeutics Holdings Inc	US$ 10.4057 (-21.17%)	74.64k
ZCARZoomcar Holdings Inc	US$ 0.595 (-20.67%)	841.76k
APTOAptose Biosciences Inc	US$ 0.1964 (31.02%)	123.45M
PLTRPalantir Technologies Inc	US$ 99.32 (-11.37%)	82.22M
ADTXAditxt Inc	US$ 0.1067 (-17.03%)	76.09M
FGENFibroGen Inc	US$ 0.6974 (24.09%)	69.04M
WOKWORK Medical Technology Group Ltd	US$ 4.23 (69.88%)	65.31M